Cargando…

Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation

OBJECTIVE: To investigate the association of donor and recipient IL-15 genetic variants with HCC recurrence and prognosis after LT. METHODS: A total of 112 liver transplant patients with HBV-related HCC were enrolled. IL-15 rs10519613 and rs13122930 were genotyped in donors and recipients. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tao, Liu, Yuan, Peng, Xu, Fan, Junwei, Peng, Zhihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661074/ https://www.ncbi.nlm.nih.gov/pubmed/29162948 http://dx.doi.org/10.1155/2017/1754696

Ejemplares similares

Genetic factors underlying tacrolimus intolerance after liver transplantation
por: Liu, Yuan, et al.
Publicado: (2022)

Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis
por: Yin, Saifu, et al.
Publicado: (2023)

A new donors’ CYP3A5 and recipients’ CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients
por: Liu, Yuan, et al.
Publicado: (2017)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
por: Villeret, François, et al.
Publicado: (2023)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
por: Wang, Xian-ding, et al.
Publicado: (2021)

Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
por: Chen, Dawei, et al.
Publicado: (2013)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

Comment on: Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients
por: Akbulut, Sami, et al.
Publicado: (2021)

Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma
por: Shang, Liming, et al.
Publicado: (2017)

Correlation of HLA-DP/DQ polymorphisms with transplant etiologies and prognosis in liver transplant recipients
por: Li, Yi, et al.
Publicado: (2017)

Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma
por: Wang, Wen-Tao, et al.
Publicado: (2016)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
por: Li, Jian, et al.
Publicado: (2018)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function
por: Liu, Yuan, et al.
Publicado: (2019)

Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma
por: Chen, Yulong, et al.
Publicado: (2021)

Association between IRF1 Gene Expression and Liver Enzymes in HBV-infected Liver Transplant Recipients with and without Experience of Rejection
por: Nabavizadeh, S. H., et al.
Publicado: (2018)

Role of IL-4 Gene Polymorphisms in HBV-Related Hepatocellular Carcinoma in a Chinese Population
por: Lu, Yu, et al.
Publicado: (2014)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
Publicado: (2019)

Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
por: Zucker, Kelly M., et al.
Publicado: (2021)

IL-15 Harnesses Pro-inflammatory Function of TEMRA CD8 in Kidney-Transplant Recipients
por: Tilly, Gaëlle, et al.
Publicado: (2017)

Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study
por: Liu, Shuang, et al.
Publicado: (2013)

Management of HBV Infection in Liver Transplantation Patients
por: Vierling, John M.
Publicado: (2005)

Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients
por: Liang, Xie, et al.
Publicado: (2021)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis
por: Peng, Wei, et al.
Publicado: (2021)

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure
por: Wang, Ke, et al.
Publicado: (2021)

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
por: Yang, Jianming, et al.
Publicado: (2023)

The CYP3A5 genotypes of both liver transplant recipients and donors influence the time‐dependent recovery of tacrolimus clearance during the early stage following transplantation
por: Huang, Li, et al.
Publicado: (2021)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
por: Shetty, Kirti, et al.
Publicado: (2014)

CS15.1 CMV in transplant recipients
por: Tan, B.-H.
Publicado: (2011)

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
por: Ataseven, Huseyin, et al.
Publicado: (2006)

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2017)

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
por: Li, Peng, et al.
Publicado: (2021)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Author Correction: Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients
por: Liang, Xie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b52sob85724fdsc6e4o6b2p1d8